Rare diseases – an evolving medical communications landscape

A disease is considered rare when it affects fewer than 1 in 2,000 people.…


The return of our ‘boomerang’ employees

In the ever-evolving world of healthcare and medical communications, attracting…


Liquid biopsies for earlier detection of recurrent endometrial tumours

Endometrial cancer affects many thousands of women across the globe. The early…


complex science with clarity

Intelligent cell division

At nspm, we understand the importance of knowledge and of delivering accurate…


nspm merges with medcept

nspm strengthens offer with sister company merger

We are excited to announce that, as of 1 December 2022, medcept and its sister…